In a filing, Climb Bio Inc revealed its CHIEF ACCOUNTING OFFICER Pimblett Emily unloaded Company’s shares for reported $2495.0 on Dec 19 ’24. In the deal valued at $2.02 per share,1,235 shares were sold. As a result of this transaction, Pimblett Emily now holds 11,329 shares worth roughly $22658.0.
Then, Pimblett Emily sold 1,191 shares, generating $9,741 in total proceeds. Upon selling the shares at $8.18, the CHIEF ACCOUNTING OFFICER now owns 7,564 shares.
Before that, Morisset Valerie sold 69,005 shares. Climb Bio Inc shares valued at $554,170 were divested by the EVP, R&D AND CSO at a price of $8.03 per share. As a result of the transaction, Morisset Valerie now holds 31,317 shares, worth roughly $62634.0.
Leerink Partners initiated its Climb Bio Inc [CLYM] rating to an Outperform in a research note published on December 02, 2024; the price target was $10.
Price Performance Review of CLYM
On Friday, Climb Bio Inc [NASDAQ:CLYM] saw its stock jump 6.95% to $2.00. Over the last five days, the stock has lost -3.38%. Climb Bio Inc shares have risen nearly 11.11% since the year began. Nevertheless, the stocks have fallen -30.80% over the past one year. While a 52-week high of $11.55 was reached on 01/07/25, a 52-week low of $1.73 was recorded on 01/02/25. SMA at 50 days reached $2.89, while 200 days put it at $5.62.
Levels Of Support And Resistance For CLYM Stock
The 24-hour chart illustrates a support level at 1.89, which if violated will result in even more drops to 1.78. On the upside, there is a resistance level at 2.19. A further resistance level may holdings at 2.38. The Relative Strength Index (RSI) on the 14-day chart is 39.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.14%. Stochastics %K at 29.10% indicates the stock is a holding.
How much short interest is there in Climb Bio Inc?
A steep rise in short interest was recorded in Climb Bio Inc stocks on 2024-12-13, dropping by 10696.0 shares to a total of 4.93 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 4.94 million shares. There was a decline of -0.22%, which implies that there is a negative sentiment for the stock.
